Managers / Q3 2025 · view latest →
Mathes Company, Inc.
CIK 0001389223 · 12 EAST 49TH STREET, NEW YORK, NY, 10017 · 917-368-4900
Summary
Mathes Company, Inc. reported $278,541 in U.S.-listed holdings across 125 positions for Q3 2025.
Its largest position, Ishares Tr, represents 6.3% of the portfolio.
Compared with Q2 2025, the fund opened 5 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 62.2% · $173,271
- ETP · 33.4% · $93,076
- Closed-End Fund · 2.6% · $7,374
- PUBLIC · 0.8% · $2,354
- Other · 0.6% · $1,696
- Other · 0.3% · $770
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Wells Fargo DEP SH 1/1000 CL A (AA) | NEW | +21.0K | 21.0K | +$411 | $411 |
| GLWCORNING INC | NEW | +3.9K | 3.9K | +$320 | $320 |
| ABBVABBVIE INC | NEW | +1.0K | 1.0K | +$232 | $232 |
| TRVCCITIGROUP INC | NEW | +2.1K | 2.1K | +$213 | $213 |
| MOALTRIA GROUP INC | NEW | +3.2K | 3.2K | +$211 | $211 |
| FDXFedex Corp. | SOLD OUT | −12.4K | 0 | −$2,819 | $0 |
| Ishares Global Healthcare ETF | SOLD OUT | −2.8K | 0 | −$237 | $0 |
| ISHARES TR | TRIMMED | −61.6K | 4.1K | −$6,728 | $474 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $273,716 | 126 | May 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $280,379 | 126 | Feb 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $278,541 | 125 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $269,575 | 122 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $245,879 | 123 | May 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $274,031 | 124 | Jan 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $283,475 | 127 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $275,479 | 128 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $266,888 | 132 | May 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $242,696 | 129 | Jan 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $215,496 | 124 | Oct 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228,553 | 125 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 127 | Jan 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $179M | 125 | Oct 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $206M | 126 | Aug 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $292M | 131 | Feb 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $270M | 124 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $278M | 124 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $259M | 124 | Apr 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $246M | 122 | Jan 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $215M | 113 | Oct 26, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $201M | 110 | Jul 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $150M | 98 | Apr 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $214M | 122 | Jan 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $194M | 121 | Oct 21, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $189M | 121 | Jul 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $196M | 130 | May 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $159M | 122 | Jan 29, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.